Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
Thomas Jefferson University
Thomas Jefferson University
City of Hope Medical Center
Thomas Jefferson University
Eastern Cooperative Oncology Group
City of Hope Medical Center
University of Nebraska
Ohio State University Comprehensive Cancer Center
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Gruppo Italiano Malattie EMatologiche dell'Adulto
Roswell Park Cancer Institute
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Northwestern University
Rutgers, The State University of New Jersey
Roswell Park Cancer Institute
Children's Oncology Group
Fred Hutchinson Cancer Center
Novartis
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Wake Forest University Health Sciences
Jonsson Comprehensive Cancer Center
Eastern Cooperative Oncology Group
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
University of Wisconsin, Madison
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University of Texas Southwestern Medical Center
Wake Forest University Health Sciences
University of Chicago
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Swiss Cancer Institute
University of Texas Southwestern Medical Center